CCM
DXCM icon

Chimera Capital Management’s DexCom DXCM Stock Holding History

Chimera Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,976
Closed -$450K – 116
2022
Q4 		$450K Sell
3,976
-5,942
-60% -$652K 0.13% 143
2022
Q3 		$799K Buy
+9,918
New +$840K 0.22% 102

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Chimera Capital Management's DXCM Position: Q1 2023 in Review

Chimera Capital Management sold out of DexCom (DXCM) in Q1 2023, closing a stake of 3,976 shares — an estimated $450K sold.

Chimera Capital Management first reported a position in DXCM in Q3 2022 and held it in 2 quarters. The position peaked at $799K in Q3 2022. 905 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • Chimera Capital Management reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
  • Chimera Capital Management sold 3,976 DexCom shares in Q1 2023, an estimated $450K.
  • Chimera Capital Management first reported a position in DexCom in Q3 2022 and held it in 2 quarters.
  • Chimera Capital Management's DexCom position peaked at $799K in Q3 2022.
  • 905 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Chimera Capital Management's 13F filing for Q1 2023, filed 15 May 2023.